2022 Monkeypox Outbreak:
Global Trends

World Health Organization

Produced on 03 August 2022

logo

1 Overview

This report provides a global overview of the monkeypox epidemiological situation as reported to WHO as of August 03 2022. The report focuses on laboratory confirmed cases1 as defined by the WHO’s working case definition published in the Surveillance, case investigation and contact tracing for monkeypox interim guidance. Note that countries may use their own case definitions separate from those outlined in the above document. This report should be considered in the context of other WHO information products associated with the 2022 monkeypox outbreak, and monkeypox in general:

  • The biweekly Situation Report provides a comprehensive update of the monkeypox situation and response activities across a variety of domains such as epidemiology, clinical management and communications, replacing the previous Disease Outbreak News format;

  • The Emergency Dashboard provides the latest daily data on total cases and deaths of monkeypox, as well as other events and emergencies to which WHO is responding;

  • This global epidemiological report provides in-depth epidemiological information about the monkeypox situation, based primarily on case report forms provided by Member States to WHO under Article 6 of the International Health Regulations (IHR 2005).

Links to these products can be see in more detail at the end of the report.

Since 1 January 2022, cases of monkeypox have been reported to WHO from 85 Member States across all 6 WHO regions. As of August 03 2022 at 17h CEST, a total of 25,054 laboratory confirmed cases and 122 probable cases, including 11 deaths, have been reported to WHO. Since 13 May 2022, a high proportion of these cases have been reported from countries without previously documented monkeypox transmission. This is the first time that cases and sustained chains of transmission have been reported in countries without direct or immediate epidemiological links to areas of West or Central Africa.

With the exception of countries2 areas of West and Central Africa, the ongoing outbreak of monkeypox continues to primarily affect men who have sex with men (MSM) who have reported recent sex with one or multiple partners. At present there is no signal suggesting sustained transmission beyond these networks.

Confirmation of one case of monkeypox, in a country, is considered an outbreak. The unexpected appearance of monkeypox in several regions in the initial absence of epidemiological links to areas in West and Central Africa, suggests that there may have been undetected transmission for some time.

WHO assesses the global risk as Moderate. Regionally, WHO assesses the risk in the European Region as High and as Moderate in the African Region, Region of the Americas, Eastern Mediterranean Region and the South-East Asia Region. The risk in the Western Pacific Region is assessed as Low-Moderate. The IHR Emergency Committee on the multi-country outbreak of monkeypox held its second meeting on 21 July 2022. Having considered the views of committee members and advisors as well as other factors in line with the International Health Regulations (2005), the WHO Director-General declared this outbreak a public health emergency of international concern and issued temporary recommendations in relation to the outbreak.

 


  1. For the WHO European region, both confirmed and probable cases are included within confirmed case counts and detailed case data.

  2. Throughout this document, any use of the word country should be considered shorthand for a country, area, or territory

  3. All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).


2 Global situation update

The number of weekly1 reported new cases globally has increased by 18.6% in week 30 (25 Jul - 31 Jul) (n = 5,204 cases) compared to week 29 (18 Jul - 24 Jul) (n = 4,387 cases). The majority of cases reported in the past 4 weeks were notified from the European Region (59.2%) and the Region of the Americas (39.2%).

The 10 most affected countries globally are: United States of America (n = 5,825), Spain (n = 4,577), The United Kingdom (n = 2,759), Germany (n = 2,724), France (n = 2,054), Brazil (n = 1,474), Netherlands (n = 927), Canada (n = 803), Portugal (n = 633), and Italy (n = 505). Together, these countries account for 88.9% of the cases reported globally.

In the past 7 days, 20 countries reported an increase in the weekly number of cases, with the highest increase reported in United States of America. 14 countries have reported no new cases in the past 21 days.

In the past 7 days, 7 countries reported their first case. countries which reported their first case in the past 7 days are: Philippines (29 July), Montenegro (31 July), Uruguay (31 July), Liberia (01 August), Sudan (01 August), Bolivia (Plurinational State of) (03 August), Cyprus (03 August).

Global data are data collected by public sources. These data are largely aggregated cases that have been reported from open and official country sources. The below epidemic curve shows the aggregated number of cases by week according to the date of case reporting.

2.1 Epidemic curve

Epidemic curve shown for cases reported up to 01 Aug 2022 to avoid showing incomplete weeks of data.

2.2 Epidemic curve by WHO Region

Epidemic curve shown for cases reported up to 01 Aug 2022 to avoid showing incomplete weeks of data. Note different y-axis scales.

2.3 Global Map

2.4 Table - Cases and deaths by WHO Region

Total Monkeypox cases, by WHO region
From 1 Jan 2022. Data as of 03 Aug 2022
Total Confirmed Cases Total Probable Cases Total Deaths
European Region 15,957 0 2
Region of the Americas 8,644 122 2
African Region 350 0 6
Western Pacific Region 67 0 0
Eastern Mediterranean Region 28 0 0
South-East Asia Region 8 0 1
Total 25,054 122 11


2.5 Table - Cases and deaths by country

Total Monkeypox cases, by WHO region
From 1 Jan 2022. Data as of 03 Aug 2022
Total Confirmed Cases Total Probable Cases Total Deaths
Region of the Americas
United States of America 5,825 0 0
Brazil 1,474 16 1
Canada 803 104 0
Peru 313 0 0
Mexico 90 0 0
Chile 55 1 0
Puerto Rico 21 0 0
Argentina 20 0 0
Colombia 20 0 0
Ecuador 6 0 0
Dominican Republic 3 1 0
Costa Rica 3 0 0
Jamaica 2 0 0
Uruguay 2 0 0
Bahamas 1 0 0
Panama 1 0 0
Venezuela (Bolivarian Republic of) 1 0 0
Barbados 1 0 0
Martinique 1 0 0
Bermuda 1 0 0
Bolivia (Plurinational State of) 1 0 0
European Region
Spain 4,577 0 2
The United Kingdom 2,759 0 0
Germany 2,724 0 0
France 2,054 0 0
Netherlands 927 0 0
Portugal 633 0 0
Italy 505 0 0
Belgium 482 0 0
Switzerland 298 0 0
Israel 146 0 0
Austria 135 0 0
Denmark 105 0 0
Sweden 102 0 0
Ireland 97 0 0
Poland 63 0 0
Norway 57 0 0
Hungary 42 0 0
Slovenia 37 0 0
Greece 33 0 0
Luxembourg 30 0 0
Czechia 25 0 0
Romania 22 0 0
Finland 20 0 0
Malta 17 0 0
Croatia 12 0 0
Iceland 10 0 0
Serbia 10 0 0
Estonia 8 0 0
Slovakia 6 0 0
Gibraltar 5 0 0
Bulgaria 4 0 0
Andorra 3 0 0
Latvia 3 0 0
Bosnia and Herzegovina 1 0 0
Cyprus 1 0 0
Georgia 1 0 0
Montenegro 1 0 0
Russian Federation 1 0 0
Türkiye 1 0 0
African Region
Democratic Republic of the Congo 163 0 0
Nigeria 133 0 3
Ghana 34 0 1
Cameroon 7 0 0
Benin 3 0 0
Central African Republic 3 0 2
South Africa 3 0 0
Congo 2 0 0
Liberia 2 0 0
Western Pacific Region
Australia 45 0 0
Singapore 12 0 0
New Zealand 3 0 0
China 2 0 0
Japan 2 0 0
Republic of Korea 1 0 0
New Caledonia 1 0 0
Philippines 1 0 0
Eastern Mediterranean Region
United Arab Emirates 16 0 0
Lebanon 4 0 0
Saudi Arabia 4 0 0
Qatar 2 0 0
Morocco 1 0 0
Sudan 1 0 0
South-East Asia Region
India 6 0 1
Thailand 2 0 0
-
Total 25,054 122 10


2.6 Table - African Region

Summary of Monkeypox cases
As of 03 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
African Region
Democratic Republic of the Congo 163 2 0 0% 0 13 Jun 2022
Nigeria 133 1 16 0% 0 02 Jan 2022
Ghana 34 1 4 −64% 0 13 Jun 2022
Cameroon 7 0 0 0% 0 13 Jun 2022
Benin 3 0 0 0% 0 15 Jun 2022
Central African Republic 3 1 0 0% 0 13 Feb 2022
South Africa 3 0 0 0% 0 23 Jun 2022
Congo 2 0 0 0% 0 21 May 2022
Liberia 2 0 2 100% 0 01 Aug 2022


2.7 Table - Region of the Americas

Summary of Monkeypox cases
As of 03 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
Region of the Americas
United States of America 5,825 18 2,347 55% 0 03 Jun 2022
Brazil 1,474 7 778 150% 0 10 Jun 2022
Canada 803 21 59 −58% 4 03 Jun 2022
Peru 313 10 105 −7% 0 28 Jun 2022
Mexico 90 1 31 180% 0 03 Jun 2022
Chile 55 3 16 −16% 4 18 Jun 2022
Puerto Rico 21 7 8 60% 1 01 Jul 2022
Argentina 20 0 0 −100% 8 03 Jun 2022
Colombia 20 0 8 60% 0 25 Jun 2022
Ecuador 6 0 3 200% 0 14 Jun 2022
Costa Rica 3 1 2 100% 6 21 Jul 2022
Dominican Republic 3 0 0 −100% 12 06 Jul 2022
Jamaica 2 1 0 −100% 8 08 Jul 2022
Uruguay 2 1 2 100% 0 31 Jul 2022
Bahamas 1 2 0 0% 37 27 Jun 2022
Barbados 1 4 0 0% 15 19 Jul 2022
Bermuda 1 16 0 −100% 11 23 Jul 2022
Bolivia (Plurinational State of) 1 0 1 100% 0 03 Aug 2022
Martinique 1 3 0 0% 14 20 Jul 2022
Panama 1 0 0 0% 28 06 Jul 2022
Venezuela (Bolivarian Republic of) 1 0 0 0% 49 14 Jun 2022


2.8 Table - Eastern Mediterranean Region

Summary of Monkeypox cases
As of 03 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
Eastern Mediterranean Region
United Arab Emirates 16 2 0 −100% 10 24 May 2022
Lebanon 4 1 0 −100% 13 20 Jun 2022
Saudi Arabia 4 0 1 0% 2 14 Jul 2022
Qatar 2 1 0 −100% 10 21 Jul 2022
Morocco 1 0 0 0% 50 02 Jun 2022
Sudan 1 0 1 100% 2 01 Aug 2022


2.9 Table - European Region

Summary of Monkeypox cases
As of 03 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
European Region
Spain 4,577 97 839 37% 0 18 May 2022
The United Kingdom 2,759 41 327 11% 0 07 May 2022
Germany 2,724 33 265 −24% 0 20 May 2022
France 2,054 32 487 −26% 0 19 May 2022
Netherlands 927 53 109 −33% 0 22 May 2022
Portugal 633 62 45 −38% 0 17 May 2022
Italy 505 8 79 52% 0 19 May 2022
Belgium 482 42 89 10% 0 19 May 2022
Switzerland 298 34 60 140% 0 21 May 2022
Israel 146 17 25 32% 0 21 May 2022
Austria 135 15 24 4% 0 23 May 2022
Denmark 105 18 34 36% 0 23 May 2022
Sweden 102 10 21 110% 0 18 May 2022
Ireland 97 20 12 −25% 0 16 May 2022
Poland 63 2 10 −23% 0 13 Jun 2022
Norway 57 11 7 75% 0 31 May 2022
Hungary 42 4 5 0% 0 31 May 2022
Slovenia 37 18 4 −43% 0 24 May 2022
Greece 33 3 4 −64% 0 09 Jun 2022
Luxembourg 30 48 11 22% 0 16 Jun 2022
Czechia 25 2 9 350% 0 24 May 2022
Romania 22 1 2 100% 0 14 Jun 2022
Finland 20 4 3 −25% 0 20 May 2022
Malta 17 33 0 0% 0 30 May 2022
Croatia 12 3 2 −33% 0 24 Jun 2022
Iceland 10 28 1 −50% 0 09 Jun 2022
Serbia 10 1 0 −100% 0 17 Jun 2022
Estonia 8 6 4 100% 0 28 Jun 2022
Slovakia 6 1 3 200% 0 07 Jul 2022
Gibraltar 5 148 0 0% 0 02 Jun 2022
Bulgaria 4 1 0 −100% 0 23 Jun 2022
Andorra 3 39 0 −100% 0 25 Jul 2022
Latvia 3 2 0 −100% 0 03 Jun 2022
Bosnia and Herzegovina 1 0 0 0% 0 14 Jul 2022
Cyprus 1 1 1 100% 0 03 Aug 2022
Georgia 1 0 0 0% 0 15 Jun 2022
Montenegro 1 2 1 100% 0 31 Jul 2022
Russian Federation 1 0 0 0% 0 12 Jul 2022
Türkiye 1 0 0 0% 0 30 Jun 2022


2.10 Table - South-East Asia Region

Summary of Monkeypox cases
As of 03 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
South-East Asia Region
India 6 0 2 0% 1 14 Jul 2022
Thailand 2 0 1 0% 1 21 Jul 2022


2.11 Table - Western Pacific Region

Summary of Monkeypox cases
As of 03 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
Western Pacific Region
Australia 45 2 1 −67% 6 20 May 2022
Singapore 12 2 1 −80% 2 21 Jun 2022
New Zealand 3 1 1 100% 1 11 Jul 2022
China 2 0 0 0% 22 24 Jun 2022
Japan 2 0 0 −100% 7 25 Jul 2022
New Caledonia 1 4 0 0% 22 12 Jul 2022
Philippines 1 0 1 100% 5 29 Jul 2022
Republic of Korea 1 0 0 0% 42 22 Jun 2022


2.12 Table - countries with last case reported 21 or more days ago

Days since last reported case
As of 03 Aug 2022
Last Reported Case Days Elapsed
African Region
Congo 21 May 2022 74
Benin 15 Jun 2022 49
Central African Republic 3 Jul 2022 31
Cameroon 12 Jul 2022 22
Eastern Mediterranean Region
Morocco 2 Jun 2022 62
European Region
Georgia 15 Jun 2022 49
Türkiye 30 Jun 2022 34
Russian Federation 12 Jul 2022 22
Region of the Americas
Venezuela (Bolivarian Republic of) 15 Jun 2022 49
Bahamas 27 Jun 2022 37
Panama 6 Jul 2022 28
Western Pacific Region
Republic of Korea 22 Jun 2022 42
China 12 Jul 2022 22
New Caledonia 12 Jul 2022 22


2.13 Epidemic curve by country

Epidemic curve shown for cases reported up to 01 Aug 2022 to avoid showing incomplete weeks of data. In general, trends should be interpretted with caution, as the majority of countries do not report cases on a daily basis.

 


  1. Weekly reported cases, and weekly cases shown in the epidemic curve are aggregated according to international standard weeks, running from Monday to Sunday.

3 Detailed case data

Detailed case data are acquired via direct reporting of case based data via WHO Member States. Data from cases are reported1 according to the WHO minimum dataset under the International Health Regulations (IHR 2005) Article 6, and subsequently aggreagated and presented below. Note that completeness of records is variable, meaning denominators for each output may be different from one another. All of the following is derived from the detailed case data, and as a result, overall numbers may not be reflective of figures shown with aggregate case numbers. All detailed cases shown are confirmed cases, where the reporting date occured after 01 January 2022.


  1. Note that a small number of detailed case reports are constructed from official public reports about individual cases.

3.1 Reporting coverage

The detailed case dataset was last updated on August 03 2022. As of this date, the total number of detailed confirmed cases reported is 19,337, representing 83.5% of all aggregated cases reported.

The table below indicate the reporting coverage between reported aggregated confirmed cases and detailed confirmed cases by countries and per region.

Note that for all tables below, in order to best align modes of reporting, total confirmed cases are shown as of:

  1. The most recent Friday (29 July) for data in the Region of the Americas.

  2. The most recent Tuesday (02 August) for data in the European Region.

Total cases shown fully as of 03 August are shown in the global trends section.

3.1.1 Table - Coverage by region

Monkeypox reporting completeness
As of 03 Aug 20221
Total Confirmed Cases Total Detailed Confirmed Cases2 % Detailed Cases reported
European Region 15,926 15,624 98.1%
Region of the Americas 6,785 3,499 51.6%
African Region 350 173 49.4%
Western Pacific Region 67 15 22.4%
Eastern Mediterranean Region 28 24 85.7%
South-East Asia Region 8 2 25.0%
1 Total confirmed cases shown as of date of last detailed case report for the WHO Region of the Americas and WHO European Region.
2 Note that in rare cases total detailed cases may exceed total confirmed cases due to ongoing data cleaning issues

3.3 Case profile (overall)

The following outputs reflect various demographic characteristics in confirmed monkeypox cases. Note that these data are only derived from detailed case data, and as a result, total numbers of cases and deaths may differ from those reported via aggregate case data where reporting is not fully aligned.

As shown below, and stated previously, the ongoing outbreak is largely developing in MSM (Men who have Sex with Men; defined as homosexual or bisexual males in reporting forms) networks. In the following analyses, we have re-coded men reported as bisexual as MSM. Note that reported sexual orientation does not necessarily reflect who the case has had recent sexual history with nor does it imply sexual activity. Generally, severity has been low, with few reported hospitalisations and deaths:

  • 98.8% (16517/16721) of cases with available data are male, the median age is 37 years (IQR: 31 - 43).

  • Males between 18-44 years old continue to be disproportionately affected by this outbreak as they account for 76.7% of cases.

  • Of the 16,971 cases where age was available, there were 96 (0.6%) cases reported aged 0-17, out of which 25 (0.1%) were aged 0-4.

  • Among cases with known data on sexual orientation, 97.5% (7328/7514) identified as MSM. Of those identified as MSM, 73 / 7328 (1.0%) were identified as bisexual men.

  • Among those with known HIV status 37.6% (2,979/7,924) were HIV-positive. Note that information on HIV status is not available for the majority of cases, and for those for which it is available, it is likely to be skewed towards those reporting positive HIV results.

  • 339 cases were reported to be health workers. However, most were infected in the community and further investigation is ongoing to determine whether the remaining infection was due to occupational exposure.

  • Of all reported types of transmission, a sexual encounter was reported most commonly, with 4,808 of 5,255 (91.5%) of all reported transmission events.

  • Of all settings in which cases were likely exposed, the most common was in large event with sexual contacts, with 277 of 1,277 (21.7%) of all likely exposure categories.

3.3.1 Demographic Information

Note that the proportions shown below should be interpreted with caution. When considering some variables, it is more likely that a yes response will be obtained when compared to a no response after consideration of true proportions of these factors. This is most likely to be true for variables where reported answers can only be yes or no, such as HIV status, health worker status, travel history, hospitalisation, ICU, and death.

Case profiles
As of August 03 2022
Reported values1 Unknown or Missing Value
Yes No
MSM 7328 (97.5%) 186 (2.5%) 11812
HIV-Positive 2979 (37.6%) 4944 (62.4%) 11403
Health worker 339 (13.5%) 2171 (86.5%) 16816
Travel History 785 (35.3%) 1438 (64.7%) 17103
Sexual Transmission 4807 (91.5%) 447 (8.5%) 14072
Hospitalised2 561 (7.1%) 7297 (92.9%) 11468
ICU 3 (0.1%) 3715 (99.9%) 15608
Died 2 (0.0%) 10652 (100.0%) 8672
1 Note given true proportions of variables, yes reporting may be common than no reporting
2 May be hospitalised for isolation or medical treatment

3.3.2 Age-sex pyramid

3.3.3 Transmission type

Transmission data were available for 5,255/19,337 (27.2%) of cases.

When considering transmission, note that dissociation between transmission via skin-to-skin contact during sex and transmission via bodily fluids cannot be disentangled. While skin-to-skin contact with lesions remains an important transmission route, monkeypox virus has been isolated from semen samples and rectal swabs from confirmed cases.

3.3.4 Exposure settings

Exposure setting data were available for 1,212/19,337 (6.3%) of cases.

Note that multiple exposure settings can be attributed to a single case. Here, differentiation here between party settings and large events is determined by size of the event, although there is no formal size threshold to distinguish the two.

3.4 Case profile (Non-MSM)

The following outputs apply to only those individuals where sexual orientation has been reported, but it is not MSM. Non-MSM categories of sexual orientation that are reportable are:

  • Heterosexual
  • Lesbian (women who have sex with women)
  • Other

As stated above, MSM in this case refers to those who have a reported sexual orientation of MSM, and men reported as bisexual. As above, note that reported sexual orientation does not necessarily reflect persons who the case has had recent sexual history with nor does it imply sexual activity. Up until this point in time, the 2022 multi-country Monkeypox outbreak has been overwhelmingly concentrated in MSM networks. For this reason, understanding events in which non-MSM individuals have acquired monkeypox is important to monitor potential of sustained spillover into the general population.

  • 65.2% (120/184) of cases with available data are male; the median age is 34.5 years (IQR: 28-44).

  • Males between 18-44 years old account for 49.5% of cases.

  • Among those with known HIV status 7.1% (11/156) were HIV-positive. Note that information on HIV status is not available for the majority of cases, and for those for which it is available, it is likely to be skewed towards those reporting positive HIV results.

  • 2 cases were reported to be health workers. However, most were infected in the community and further investigation is ongoing to determine whether the remaining infection was due to occupational exposure.

  • Of all reported types of transmission, sexual encounter was reported most commonly, with 69 of 94 (73.4%) of all reported transmission events.

  • Of all settings in which cases were likely exposed, the most common was in households, with 10 of 44 (22.7%) of all likely exposure categories.

3.4.1 Demographic Information

Note that the proportions shown below should be interpreted with caution. When considering some variables, it is more likely that a yes response will be obtained when compared to a no response after consideration of true proportions of these factors. This is most likely to be true for variables where reported answers can only be yes or no, such as HIV status, health worker status, travel history, hospitalisation, ICU, and death.

Case profiles (Non-MSM)
As of August 03 2022
Reported values1 Unknown or Missing Value
Yes No
MSM 0 186 (100.0%) 0
HIV-Positive 11 (7.1%) 145 (92.9%) 30
Health worker 2 (1.9%) 106 (98.1%) 78
Travel History 24 (34.8%) 45 (65.2%) 117
Sexual Transmission 69 (73.4%) 25 (26.6%) 92
Hospitalised2 34 (19.2%) 143 (80.8%) 9
ICU 0 89 (100.0%) 97
Died 0 180 (100.0%) 6
1 Note given true proportions of variables, yes reporting may be common than no reporting
2 May be hospitalised for isolation or medical treatment

3.4.2 Age-sex pyramid

3.4.3 Transmission type

Transmission data were available for 94/186 (50.5%) of cases.

When considering transmission, note that dissociation between transmission via skin-to-skin contact during sex and transmission via bodily fluids cannot be disentangled. While skin-to-skin contact with lesions remains an important transmission route, monkeypox virus has been isolated from semen samples and rectal swabs from confirmed cases.

3.4.4 Exposure settings

Exposure setting data were available for 43/186 (23.1%) of non-MSM cases.

Note that multiple exposure settings can be attributed to a single case. Here, differentiation here between party settings and large events is determined by size of the event, although there is no formal size threshold to distinguish the two.

3.5 Symptomatology

Although most cases in current outbreaks have presented with mild disease symptoms, monkeypox virus (MPXV) may cause severe disease in certain population groups (young children, pregnant women, immunosuppressed persons)

Among the cases who reported at least one symptom, the most common symptom is any rash and is reported in 83% of cases with at least one reported symptom. Note that identifying true denominators for symptomatology is difficult due to a general lack of negative reporting and symptom definitions that may vary between countries’ reporting systems.

A bar chart and table showing symptoms is shown below. Here any rash refers to one or more rash symptoms (systemic, oral, genital, or unknown location), and any lymphadenopathy refers to either general or local lymphadenopathy.

3.5.1 Bar chart - Symptoms

3.5.2 Table - Symptoms

Summary of symptoms
As of August 03 2022
Number
Any rash 10690 (83.4%)
Systemic rash 8294 (64.7%)
Fever 5569 (43.5%)
Genital rash 4663 (36.4%)
Any lymphadenopathy 3736 (29.2%)
Lymphadenopathy 3665 (28.6%)
Local lymphadenopathy 3084 (24.1%)
Fatigue 2575 (20.1%)
Headache 2429 (19.0%)
Muscle ache 2354 (18.4%)
Asymptomatic 1759 (13.7%)
Oral rash 1197 (9.3%)
Cough 175 (1.4%)
Vomiting 73 (0.6%)
Chills 0
Conjunctivitis 0
Sore throat 0
Other 0

 


4 In focus: West and Central Africa

Since 1970, human cases of monkeypox have been reported in 9 countries in the WHO African region: Cameroon, Central African Republic, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Gabon, Liberia, Nigeria, and Sierra Leone. The true burden of monkeypox in these countries is not known. This section specifically focuses on those countries in the African region with a history of monkeypox, in order to highlight any differences in epidemiology between those countries and those within the ongoing 2022 monkeypox outbreak without a history of monkeypox. Notably, while the ongoing 2022 monkeypox outbreak has been associated with the west African clade of the monkeypox virus, historically outbreaks have been driven by that and the central African clade.

Historically, the sexual component of transmission in the countries above has been thought to contribute less to human to human transmission of monkeypox than has been observed in the ongoing global outbreak. It should also be noted that there is limited testing capacity for monkeypox in many of these countries, which has led to underascertainment of monkeypox cases.

In 2022, as of 03 Aug 2022, there have been 310 confirmed cases of monkeypox reported in these countries and 5 deaths. These represent 1% and 45% of global cases and deaths respectively. In addition, 173 (56% of all cases) detailed cases have been reported to WHO.

Of those cases with detailed data:

  • 110 male cases (64.3%) and 61 female cases (35.7%) have been reported

  • The median age is 25 (IQR: 11 - 35).

  • Of the 168 cases where age was available, there were 65 (38.7% of total) cases reported aged 0-17, out of which 21 (12.5% of total) were aged 0-4.

  • There are currently no detailed cases for which transmission or exposure setting detail is available

Trends from these countries are shown below:

4.1 Epidemic curve by date of notification

Epidemic curve shown for cases reported up to 01 Aug 2022 to avoid showing incomplete weeks of data.

4.2 Epidemic curve by date of onset

This epidemic curve is shown for those cases with detailed case data, giving date of onset.

4.3 Age-sex pyramid

 


5 Disclaimers

Users are advised to interpret all data with caution and be aware of their limitations. Case counts and their corresponding data may be retrospectively corrected as new information is collected and reported.

6 Acknowledgements

We gratefully acknowledge the input of national public health staff involved in surveillance activities and data submission to WHO, the European Centre for Disease Prevention and Control (ECDC) for the provision of surveillance data collected via the TESSy platform, as well as external partners who contributed additional insights and contextual information on the data.